Program - Pharma 2026 (english)

About the event Program Speaker Partner Organisation

Tickets

Monday, 9 February 2026

Focus Day Technology – AI in Pharma

From molecule to market: How much efficiency and quality lies in the AI revolution?

The Focus Day explores concrete application areas of artificial intelligence across the entire pharmaceutical value chain – from molecules to healthcare delivery. The emphasis: transferable business relevance and best practices.

09:30

Registration and Networking Breakfast

10:00

Insights on current investigations and industry news from the Handelsblatt editorial team

Live Editorial

Helena Smolak Editor for Pharmaceuticals – Handelsblatt

10:10

Political Keynote

(in final coordination)

10:20

Interview with the Handelsblatt Editorial Team

10:30

Agentic AI in Pharma

Keynote

Aditya Kudumala Principal, Life Science Strategy – Deloitte, New York

10:50

Presentation

(in final coordination)

11:10

Artificial Intelligence in Healthcare Delivery: Opportunities and Limits Between Patients, Physicians and Industry

Panel Discussion

Moderator: Sandra Groeneveld, Editor & Host of “Handelsblatt Today” – Handelsblatt

Andreas Pollner General Manager – Moderna Germany Mehr Informationen

Additional speakers in final coordination

11:40

Networking Break

AI for Discovery – Molecules & Targets: How Algorithms Accelerate the Development of New Therapeutics

12:10

AI Biotech in Action: How Multimodal Data Is Shaping the Next Generation of Drug Discovery and Development

Thomas Clozel Chief Executive Officer – OWKIN – New York

12:30

Toward Pharmaceutical Superintelligence: From Speed Benchmarks to Genuine Invention

Alex Zhavoronkov Founder and CEO – Insilicio Medicine, Cambridge, USA

12:50

From Superintelligence to Safe Innovation: How AI-Driven Drug Discovery Will Transform Evidence, Trials and Regulation

Panel Discussion

Moderator: Helena Smolak, Editor Pharma – Handelsblatt

Prof. Dr. Karl Broich President – Federal Institute for Drugs and Medical Devices (BfArM)

Christiane Rothkegel, Ph.D. Regulatory Senior Program Director – Roche – Basel Mehr Informationen

Alex Zhavoronkov Founder and CEO – Insilicio Medicine, Cambridge, USA

01:20

Networking Break & Lunch

Smart Clinical Trials – Clinical Development: How AI Makes Trials Faster, Smaller and Smarter

02:20

Best Practices: AI Digital Twins with Foundation Models

Jean-Philippe Vert Co-Founder und CEO – Biooptimus – Paris Mehr Informationen

AI in Market Access – Pricing & Reimbursement: From Dossier to Deal – AI in Benefit Assessment

02:40

Automated Market Access: How AI Radically Accelerates the Path from Evidence to Reimbursement

Jonas Ils Co-Founder – RYVER.AI

03:00

From File to Formula: How AI Reinvents Pricing & Market Access for Drug Launches

Daniel Moreira Co Founder – Cellbyte

03:20

Networking Break

Beyond Approval – Care Delivery, Framework Conditions & Post-Market

03:50

Research, Talent, Investment and Business Models – What Framework Does Technology Need in Germany and Europe?

Panel Discussion

Moderator: Helena Smolak, Editor Pharma – Handelsblatt

Dr. Daniel Steiners CEO – Roche Pharma AG Mehr Informationen

Dr. Justus Wolff Member of the EU Focus Group on AI – Member ISPOR

Additional speakers in final coordination

04:10

Enhancing Efficiency & Quality in Medical Evidence Generation: AI in Post-Approval Studies and Communication

Dr. Monika Gratzke European Head of Medical Innovation & Digital Strategy – Daiichi Sankyo Europe

04:30

From Data Fragments to Care Intelligence: How AI Transforms RWE Generation and Safety Assessment

Dr. Benjamin Gmeiner Director Medical Data Strategy & Science – Novartis Deutschland

04:50

Real-Time Digital Pathology: How AI Makes Cancer Diagnostics Faster, More Precise and Scalable

Felix Faber Founder & Chief Executive Officer – Mindpeak

05:10

Summary of the Day

05:30

End of “Focus Day Technology – AI in Pharma”

from 06:30

International Strategic Meet-Up (sold out)

Science, Strategy & Scale – Shaping Europe’s Pharma Transformation

(Event held in English; off-site location)

06:45

Welcome

07:00

Science, Strategy & Scale – Shaping Europe’s Pharma and Healthcare Transformation under Global Pressure

Panel Discussion

Moderator: Martin Knobbe, Member of the Editorial Board, Handelsblatt

Chantal Friebertshäuser Senior Vice President Europe, Middle-East and international tenders – Moderna

Prof. Dr. Prof. Dr. Heyo Kroemer Chair of the Executive Board – Charité – Universitätsmedizin Berlin

Marc P. Philipp Partner & Managing Director – Kearney Mehr Informationen

European policy leaders and pharma C-level executives in final alignment

Host International Strategic Meet Up

KEARNEY

Tuesday, 10 February 2026

Focus Day: Industrial Competitiveness
Europe as a Business Location – Opportunities, Risks, Future Outlook

09:00

Registration

09:30

Welcome

09:40

Insights on current investigations and industry news from the Handelsblatt editorial team

Live Editorial

Britta Rybicki Editor for Health Policy – Handelsblatt

Helena Smolak Editor for Pharmaceuticals – Handelsblatt

Europe as a Pharma Location – Between Innovation Strength and Relocation Risks

09:50

Renewing Europe’s Strength: Pharma as a Strategic Industry

Opening Commentary

Han Steutel President – Association of Research-Based Pharmaceutical Companies (vfa)

10:10

Political Keynote

(in final coordination)

10:30

Interview with the Handelsblatt Editorial Team

Britta Rybicki Editor for Health Policy – Handelsblatt

10:40

Tailwinds or Headwinds for a Key Industry? Market and Economic Outlook for the Pharmaceutical Sector from a Financial Perspective

Dr. Jürgen Michels Chief Economist & Head of Research – Bayrische Landesbank Mehr Informationen

11:00

Networking Break

11:30

Impulse

Marc P. Philipp Partner & Managing Director – Kearney Mehr Informationen

11:40

Leave or Stay? Strategic Trade-Offs and Framework Conditions Shaping Germany’s Attractiveness as a Pharma Location

Round Table

Moderator: Dr. Gerd Wirtz, Science Journalist & Expert in Future Medicine

Christiane Bardroff Chief Operating Officer (COO) – Rentschler Biopharma

Dorothee Brakmann Chief Executive Officer – Pharma Deutschland e.V. Mehr Informationen

Marc P. Philipp Partner & Managing Director – Kearney Mehr Informationen

Prof. Dr. Jens Südekum Government Advisor and Professor of International Economics – Heinrich Heine University Düsseldorf

Additional speakers in final coordination

12:15

Competing on Equal Footing? International Locations in Comparison

Live Correspondent Links

Martin Benninghoff China Correspondent (Shanghai) – Handelsblatt Mehr Informationen

Laurin Meyer U.S. Correspondent – Handelsblatt

12:30

Industrial Growth at the Expense of the Future? Balancing Competitiveness and a Solidarity-Based Healthcare System

Panel Discussion

Moderator: Sandra Groeneveld, Editor & Host of “Handelsblatt Today” – Handelsblatt

Thomas Ballast Deputy Chairman of the Executive Board – Techniker Krankenkasse

Frank Lucaßen Chief Executive Officer – medac Mehr Informationen

Dr. Maria Lena Weiss Member of the Health Committee & Rapporteur for the Healthcare Industry – CDU/CSU Parliamentary Group (German Bundestag) Mehr Informationen

13:00

Networking & Lunch

02:10

Digital Transformation and RNAi: The Role of Regional AI Adaptation in Delivering Innovative Therapies

Impulse

Dr. Sarah Adams, MD, eMBA Senior Country Medical Director Germany – Alnylam Pharmaceuticals

EU Frameworks – Pharma Package, EU HTA, EHDS & AI Regulation

02:30

Health Data in Germany and Europe: How Evidence, Data Infrastructure and AI Redefine Care

Dr. Frank Wartenberg President & GM – Germany & Austria Mehr Informationen

02:50

A Regulatory Turning Point in Europe? What New Frameworks Mean for Business, Data and Innovation

Power Talk

Dr. Jasmina Kirchhoff Project Lead Pharma Location Germany – German Economic Institute (IW)

Dr. Marco Penske Head Market Access & Healthcare Affairs – Boehringer Ingelheim Mehr Informationen

03:10

Networking Break

New Business Foundations, Supply Security & Supply Chain Resilience

03:40

Building Sustainable and Resilient European Production

Best Practice Session

Dr. Sandra Kluge Head of Communications & Health Policy – Chiesi GmbH Mehr Informationen

04:00

The Future Pharma Commercial Model: Resilience by Design

Kevin Santo Co-Head Germany – ZS

Eva Stuckmeyer Co-Head Germany – ZS Mehr Informationen

04:20

Resilience or Bottleneck? Supply Security, Location Conditions and Supply Chains in Germany and Europe

Panel Discussion

Moderator: Helena Smolak, Editor Pharma – Handelsblatt

Dr. Kai Joachimsen Chief Executive Officer – German Association of the Pharmaceutical Industry (BPI) Mehr Informationen

Kerem Inanc Chief Executive Officer – Alliance Healthcare Germany

Tim Steimle Head of Pharmaceuticals Division – Techniker Krankenkasse

Thomas Weigold Country President Sandoz Germany & CEO – Hexal

05:00

Impulse

(in final coordination)

05:20

Closing Summary & Farewell

05:30

End of “Focus Day: Industrial Competitiveness”

from 06:30

Networking Dinner

Strengthen and expand your network at our central evening event.

Host

Wednesday, 11 February 2026

Focus Day: Market Access & Approval
AMNOG 2.0 – Market Approval and Pricing in Transition

09:30

Registration

09:45

New Frameworks: Pharma Strategy, Supply Security and Statutory Health Insurance Finances

Keynote

Thomas Müller Director General, Department “Medicinal Products, Medical Devices and Biotechnology” – Federal Ministry of Health (Germany)

10:05

Interview with the Handelsblatt Editorial Team

Thomas Müller Director General, Department “Medicinal Products, Medical Devices and Biotechnology” – Federal Ministry of Health (Germany)

Britta Rybicki Editor for Health Policy – Handelsblatt

Confidential Prices, Early Data – Opportunities or Barriers to Care?

10:20

Price Differentiation in AMNOG Based on Evidence: Why the Current Model Is Not Yet Future-Proof

Commentary

Dr. Antje Haas Head of Department for Pharmaceuticals and Remedies – National Association of Statutory Health Insurance Funds (GKV-Spitzenverband)

10:50

Early Data, Early Conflict? EU HTA, AMNOG and the Battle over Evidence Quality

Panel Discussion

Moderator: Helena Smolak, Editor Pharma – Handelsblatt

Britta Bickel Head of Team “Early Benefit Assessment” – National Association of Statutory Health Insurance Physicians (KBV)

Dr. Antje Haas Head of Department for Pharmaceuticals and Remedies – National Association of Statutory Health Insurance Funds (GKV-Spitzenverband)

Christian Lauterbach Managing Director – Bayer Vital Mehr Informationen

11:20

Networking Break

11:50

Global Markets, New Prices? How Geopolitical Developments Are Changing the Rules of Market Access

Panel Discussion

Moderator: Helena Smolak, Editor Pharma – Handelsblatt

Heidrun Irschik-Hadjieff Chair of the Management Board – Sanofi

Dr. Christian Rybak Chair Health Care & Life Sciences Germany – Greenberg Traurig, Germany Mehr Informationen

Dr. Julian Witte Managing Director & Author of the AMNOG Report – Vandage

Obesity Therapies, Alzheimer’s & ATMPs
Medical Disruptions – From Hype to Reality in Care Delivery

12:20

From Niche to Next-Gen Care: Rare Diseases in the Era of Personalised Medicine

Speakers in final coordination

12:50

When Innovation Becomes Systemically Unsustainable: Medical Disruptions from Hype to Real-World Care

Panel Discussion

Moderator: Sandra Groeneveld, Editor & Host of “Handelsblatt Today” – Handelsblatt

Tobias Gemmel Vice President Market Access & Strategic Pricing – Novo Nordisk Pharma Mehr Informationen

Dr. Petra Nies Head of Department for Pharmaceuticals – Federal Joint Committee (G-BA)

Prof. Dr. Andrew Ullmann Board Member – Professional Association of German Internists (BDI)